Critical Insights into Novel Immunomodulatory Therapy for Sepsis: Evaluating Promise Amidst Limitations

Varun M Angadi; Pratyusha Kambagiri; Atul Jindal

doi:10.5005/jp-journals-10071-24847

SEARCH WITHIN CONTENT

Online First

Critical Insights into Novel Immunomodulatory Therapy for Sepsis: Evaluating Promise Amidst Limitations

Varun M Angadi, Pratyusha Kambagiri, Atul Jindal

Keywords : Hemoperfusion, Immunomodulation, Polymyxin B, Sepsis

Citation Information : Angadi VM, Kambagiri P, Jindal A. Critical Insights into Novel Immunomodulatory Therapy for Sepsis: Evaluating Promise Amidst Limitations. Indian J Crit Care Med 2025; 29 (1):90-90.

DOI: 10.5005/jp-journals-10071-24847

License: CC BY-NC 4.0

Published Online: 30-12-2024

ARTICLE
REFERENCES

Abstract

PDF Share

Ghosh I, Sangha S, Pandey G, Srivastava A. Efficacy of polymyxin B hemoperfusion for treatment of sepsis. Indian J Crit Care Med 2024;28(10):930–934. DOI: 10.5005/jp-journals-10071-24805.
Mithal LB, Arshad M, Swigart LR, Khanolkar A, Ahmed A, Coates B. Mechanisms and modulation of sepsis-induced immune dysfunction in children. Pediatr Res 2021;91(2):447. DOI: 10.1038/s41390-021-01879-8.
Li X, Liu C, Mao Z, Qi S, Song R, Zhou F. Effectiveness of polymyxin B-immobilized hemoperfusion against sepsis and septic shock: A systematic review and meta-analysis. J Crit Care 2021;63:187–195. DOI: 10.1016/j.jcrc.2020.09.007.
Robey RC, Logue C, Caird CA, Hansel J, Hellyer TP, Simpson J, et al. Immunomodulatory drugs in sepsis: A systematic review and meta-analysis. Anaesthesia 2024;79(8):869–879. DOI: 10.1111/anae.16263.
Jain A, Singam A, Mudiganti VNKS. Recent advances in immunomodulatory therapy in sepsis: A comprehensive review. Cureus 2024;16(3):e57309. DOI: 10.7759/cureus.57309.

PDF Share